Craig Laughton

424 total citations
8 papers, 361 citations indexed

About

Craig Laughton is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Craig Laughton has authored 8 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Craig Laughton's work include Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Cancer, Lipids, and Metabolism (2 papers) and 3D Printing in Biomedical Research (2 papers). Craig Laughton is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Cancer, Lipids, and Metabolism (2 papers) and 3D Printing in Biomedical Research (2 papers). Craig Laughton collaborates with scholars based in United States, France and Poland. Craig Laughton's co-authors include Carl M. Mendel, Margarete Mehrabian, Aldons J. Lusis, J. H. Qiao, Richard W. Hyman, Francis S. Greenspan, Juan Carlos Jaume, Philip H. Frost, Elliott Sigal and Mary A. Mulkins and has published in prestigious journals such as Analytical Biochemistry, Annals of the New York Academy of Sciences and Biochemical Pharmacology.

In The Last Decade

Craig Laughton

8 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig Laughton United States	7	128	115	77	44	40	8	361
Yoshifumi Okura Japan	9	117 0.9×	94 0.8×	106 1.4×	49 1.1×	31 0.8×	22	336
S. Tagami Japan	9	172 1.3×	70 0.6×	50 0.6×	81 1.8×	81 2.0×	14	549
NC Wong Canada	9	193 1.5×	85 0.7×	83 1.1×	35 0.8×	97 2.4×	13	402
Sean J. P. GAVIGAN United Kingdom	8	102 0.8×	177 1.5×	152 2.0×	25 0.6×	40 1.0×	9	381
Rie Shibayama Japan	8	81 0.6×	147 1.3×	30 0.4×	67 1.5×	58 1.4×	11	413
C. Copin France	10	190 1.5×	115 1.0×	133 1.7×	62 1.4×	48 1.2×	11	428
E Liong Hong Kong	11	177 1.4×	80 0.7×	85 1.1×	39 0.9×	37 0.9×	15	429
Biddanda C. Ponnappa United States	15	239 1.9×	54 0.5×	135 1.8×	30 0.7×	47 1.2×	26	517
Jacqueline Etienne France	13	165 1.3×	114 1.0×	69 0.9×	57 1.3×	160 4.0×	23	482
Rolf Eckey Germany	10	145 1.1×	68 0.6×	66 0.9×	38 0.9×	56 1.4×	17	424

Countries citing papers authored by Craig Laughton

Since Specialization

Citations

This map shows the geographic impact of Craig Laughton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Laughton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Laughton more than expected).

Fields of papers citing papers by Craig Laughton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Laughton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Laughton. The network helps show where Craig Laughton may publish in the future.

Co-authorship network of co-authors of Craig Laughton

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Laughton. A scholar is included among the top collaborators of Craig Laughton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Laughton. Craig Laughton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Jaume, Juan Carlos, Carl M. Mendel, Philip H. Frost, Francis S. Greenspan, & Craig Laughton. (1996). Extremely Low Doses of Heparin Release Lipase Activity into the Plasma and Can Thereby Cause Artifactual Elevations in the Serum-Free Thyroxine Concentration as Measured by Equilibrium Dialysis. Thyroid. 6(2). 79–83. 70 indexed citations

2.

Sigal, Elliott, Craig Laughton, & Mary A. Mulkins. (1994). Oxidation, Lipoxygenase, and Atherogenesis. Annals of the New York Academy of Sciences. 714(1). 211–224. 36 indexed citations

3.

Mehrabian, Margarete, et al.. (1993). Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(1). 1–10. 111 indexed citations

4.

Mendel, Carl M., Craig Laughton, Francis A. McMahon, & Ralph R. Cavalieri. (1991). Inability to detect an inhibitor of thyroxine-serum protein binding in sera from patients with nonthyroid illness. Metabolism. 40(5). 491–502. 32 indexed citations

5.

Lee, Chi-Ho, et al.. (1989). Tissue selectivity of propranolol derivatives in vivo. Biochemical Pharmacology. 38(10). 1563–1567. 3 indexed citations

6.

Laughton, Craig, et al.. (1988). Sera containing elevated nonesterified fatty acids from patients with angiographically documented coronary atherosclerosis cause marked lipid accumulation in cultured human arterial smooth muscle-derived cells. Atherosclerosis. 70(3). 233–246. 29 indexed citations

7.

Laughton, Craig. (1986). Measurement of the specific lipid content of attached cells in microtiter cultures. Analytical Biochemistry. 156(2). 307–314. 29 indexed citations

8.

Laughton, Craig. (1984). Quantification of attached cells in microtiter plates based on Coomassie brilliant blue G-250 staining of total cellular protein. Analytical Biochemistry. 140(2). 417–423. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact